Principal Investigator
Amer Beitinjaneh
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20240469
Clinical Trial Summary
CD4CAR T CELL THERAPY FOR AML
Phase
Phase I
Funding Agency/Sponsor
Institutional
Disease
Transplant/cellular therapy
Contact Information
Phone Number
+1 (954) 8177628